16 Jul 2018

Plan for phased re-introduction of hepatitis B vaccine for travellers

Public Heath England has agreed to accelerate the phased reintroduction of vaccine Plan for phased re-introduction of hepatitis B vaccine for travellers

Public Health England (PHE) advises that vaccine manufacturers GlaxoSmithKline (GSK) consider that the supplies of adult and paediatric Hepatitis B vaccine (Engerix B®) and renal vaccine (Fendrix®) are now sufficient to supply the UK market. Merck Sharp Dohme (MSD) UK expects current supplies of adult vaccine (HBvaxPRO™ 10mcgs) to last until October 2018 and then supplies will not resume until 2020 [1].

PHE has agreed to accelerate the phased reintroduction of vaccine outlined in the recovery plan, so that vaccine is now available for all priority groups 1 to 4 [1].

Combined hepatitis A/B vaccine continues to be available and is the preferred first line choice for travellers [2,3]. For those who have previously received hepatitis A vaccine, and require a primary course of hepatitis B for travel to countries where there is a NaTHNaC hepatitis B vaccine recommendation, single antigen hepatitis B vaccine, can be offered [1].

Advice for travellers

Advice on hepatitis B risk in specific countries is available on the TravelHealthPro Country Information pages.

Resources

Polio: Public Health Emergency of International Concern

An update on the polio Public Health Emergency of International Concern (PHEIC) Read more

Global wildfires

A wildfire is an unplanned fire in a natural area such as forest, grassland or prairie Read more

Ebola virus disease (EVD): Democratic Republic of Congo- update

New confirmed cases continue to be reported in North Kivu and Ituri Provinces Read more

Measles outbreaks in the pacific and new entry requirements for travellers

An outbreak of measles is currently affecting a number of islands in the Pacific- travellers should check for possible new entry requirements Read more
Back to Top

VIEW FULL INDEX